Prostate-specific membrane antigen (PSMA) based DNA/RNA aptamers enhance the efficacy of the deep learning model for the precise diagnosis to prostate cancer
We suggest replacing prostate-specific antigen (PSA) with targeted prostate-specific membrane antigen (PSMA)-aptamers in the deep learning (DL) model to effectively overcome the limitation of non-specificity of the biomarker in the differential diagnosis of prostate cancer.
Possible strategies for mRNA nanovaccines targeting virus-infected diseases
The research of an unconventional nanovaccine based on the immunogenic-free nano-delivery system would be highly recommended.